Medinice presents PacePress® clinical trial results on BIZNES24
August 19, 2025
Medinice CEO on BIZNES24: Clinical Trials of PacePress® Successfully Completed
On BIZNES24 TV, Medinice S.A. CEO Sanjeev Choudhary announced the completion of clinical trials for the innovative PacePress® project.
The multicenter study, conducted across six leading hospitals in Poland, confirmed the device’s clear advantages in reducing hemorrhagic complications following Cardiac Implantable Electronic Device (CIED) implantation. Results show that PacePress® significantly lowers the risk of hematomas and infections, shortens hospitalization time, improves patient comfort, and enhances both therapy safety and clinical monitoring effectiveness.
"Thanks to these clinical data, PacePress® becomes the foundation for the next stage – faster commercialization and the introduction of our technology to global markets," emphasized CEO Sanjeev Choudhary.
The completion of the study marks an important step in Medinice S.A.’s mission to set new standards of patient safety in cardiology procedures.
Detailed information about the medical device PacePress® can be found under the following link:
Learn moreWe Care About Your Privacy
Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.